SynthesisFrontiers in microbiology2026
Global research trends in stroke and gut microbiota: a multi-database bibliometric analysis and cross-validation study.
Synthesis in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The fields of stroke and the gut microbiota are closely linked via the "gut-brain axis," and their complex bidirectional interactions have emerged as a significant research focus. This study represents the first systematic bibliometric analysis of this field, aiming to delineate its knowledge structure, evolutionary trajectory, current research hotspots, and emerging frontiers. Methods: Data for this study were retrieved from the Web of Science Core Collection, covering the period from January 1, 2000, to August 31, 2025. Following a screening process, a total of 1,236 relevant articles were included in the analysis. Bibliometric and visualization tools, including CiteSpace, VOSviewer, R software, and Microsoft Excel, were employed to systematically analyze the distribution of research disciplines, publication output, contributions by country/region, institutional collaborations, influential authors, core journals, co-cited references, and keyword co-occurrence. Furthermore, to assess the robustness of our findings and explore characteristic differences across databases, we performed a multi-database validation and comparative analysis using data from Scopus and PubMed. Results: The number of annual publications has shown a continuous increase, with a rapid surge in the number of articles published over the past 5 years, achieving an average annual growth rate of 20.6%. China leads the world in terms of the number of publications, while the United States plays a central role in early-stage research and international collaboration. This study demonstrates significant interdisciplinary integration, encompassing multiple disciplines including neuroscience, pharmacology, immunology, and microbiology. Current research hotspots focus on the interaction between gut microbiota dysbiosis and post-stroke neuroinflammation, the therapeutic potential of microbial metabolites (e.g., short-chain fatty acids), the exploration of gut-brain axis mechanisms, and probiotic intervention strategies. Mechanistic research and clinical translation have been identified as the primary drivers for the development of this field. Multi-database validation showed that the annual publication trends, keyword distribution, and rankings of major contributing countries were consistent. Conclusion: Current research hotspots have expanded from basic mechanisms toward clinical translation, underscoring the importance of elucidating common pathophysiological mechanisms and identifying potential therapeutic targets. Future research priorities include refining screening and diagnostic protocols for gut microbial biomarkers, developing effective prevention strategies based on probiotics and other microbiota-targeted interventions, and advancing individualized and targeted therapeutic approaches. By integrating multi-omics data with precision medicine approaches, the field is poised to further accelerate the translation of mechanistic discoveries into clinical practice, ultimately offering novel strategies for the prevention and treatment of stroke.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.